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Abstract
The preparations of polyhydric alcohols, namely sorbitol-based ones, and their combination with adjuvant therapy, namely
L-arginine are sufficiently promising for treatment of purulent-septic complications. The systemic nature of their action
makes it appropriate to carry out studies of specific effect on the circulatory system, since their wide homeostatic and
pharmacodynamic spectrum is beyond doubt for other systems and organs within the “efficiency-safety” algorithm.
The objective of the research was to study the effect of combined use of sorbilact and L-arginine on the cardiovascular system
of patients with endogenous intoxication syndrome during the period of developing early secondary autoaggression.
Materials and methods. The study included 117 patients who were divided into the following groups: Group I consisted
of 31 patients with systemic inflammatory response syndrome; Group II included 27 patients with endogenous intoxication
syndrome treated according to 2016 Surviving Sepsis Campaign; Group III comprised 29 patients with endogenous
intoxication syndrome who received sorbilact in addition to standard therapy; Group IV included 30 patients with systemic
inflammatory response syndrome who received standard therapy as well as sorbilact and L-arginine.
Results. Co-administration of sorbilact and L-arginine was accompanied by an increase in stroke volume and cardiac output,
activation of left ventricular minute work alongside with a moderate decrease in mean arterial pressure and systemic vascular
resistance.
Conclusions. The application of sorbilact and L-arginine in patients with endogenous intoxication syndrome provides
hemodynamic stability.
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Problem statement and analysis of the
recent research
Despite considerable progress, treatment of purulent-septic
complications remains the focus of clinical medicine [1].
Purulent-septic complications, as well as sepsis, cause mul-
tiple organ dysfunction syndrome, the characteristic feature
of which is accumulation of endotoxins and, accordingly, the
development of toxemia [2, 5]. Fluid resuscitation is the ba-
sis of intensive therapy for toxemia of septic origin. In fluid
resuscitation, various fluids are used: crystalloids, albumin,
optionally colloids [3]. The preparations of polyhydric alco-
hols, namely sorbitol-based ones, and their combination with
adjuvant therapy, namely L-arginine are sufficiently promising
[4,7]. The systemic nature of their action makes it appropri-
ate to carry out studies of specific effect on the circulatory
system, since their wide homeostatic and pharmacodynamic
spectrum is beyond doubt for other systems and organs within
the “efficiency-safety” algorithm [6].
The objective of the research was to study the effect of
combined use of sorbilact and L-arginine on the cardiovascu-
lar system of patients with endogenous intoxication syndrome
(EIS) during the period of developing early secondary autoag-
gression.
1. Materials and methods
The following groups of patients were included in our study:
• Group I, (the control group) consisted of 31 patients
with systemic inflammatory response syndrome (SIRS)
(ICD-10: R-65.2);
• Group II included 27 patients with EIS of purulent-
septic genesis who were sorted by the level of cell-
mediated and humoral intoxication index (CHII) [8]
with 40-60 scores and treated according to 2016 Surviv-
ing Sepsis Campaign (standard therapy) [9];
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• Group III comprised 29 patients with EIS of purulent-
septic genesis with 40-60 CHII scores, who received
sorbilact in addition to standard therapy;
• Group IV included 30 patients with EIS of purulent-
septic genesis with 40-60 CHII scores, who received
standard therapy as well as sorbilact and L-arginine.
Inclusion criterion in groups II-IV was acute purulent sur-
gical infection of different localization associated with aerobic
gram-positive and gram-negative flora with the subsequent
development of secondary toxic autoaggression (stratified to
scale of CHII of more than 40 scores).
All the patients received standard combination therapy
according to 2016 Surviving Sepsis Campaign [9] (surgical
sanitation of the focus of infection, antibiotic therapy, infu-
sion therapy, rheological, metabolic and inotropic support,
etc.). Medications affecting the cardiovascular system were
not used in the period of the study. Sorbilact infusion to pa-
tients of Group III and Group IV was carried out at a rate of
6-7 ml/kg body weight intravenously with the administration
rate of 7-8 ml/min. Then, patients of Group IV were intra-
venously infused with 4.2% solution of L-arginine (Tivortin);
administration rate according to the instructions.
Exclusion criterion was the emergence of one or more
circumstances that were not included in inclusion criteria,
namely supplementing intensive therapy with hemodialysis,
plasmapheresis, artificial ventilation, hyperbaric oxygenation;
a significant deterioration of the general condition due to the
activation of comorbid diseases or the progression of com-
plications, which required the use of intensive care measures
that did not meet inclusion criteria.
The statistical analysis of the data was performed using
Student’s t-test for independent samples by means of the IBM
Packs SPSS Statistics 8. The determination of hemodynamic
parameters was carried out 3 hours (±10 min) after sorbilact
infusion. Central venous pressure (CVP) was measured using
the Waldman phlebotonometer. To measure stroke volume
(SV), the portable ultrasound system ”High Technology PU-
2200” was used.
2. Results and discussion
Acute endogenous intoxication triggers disregulatory changes
in the circulatory system manifesting themselves as increased
systemic vascular resistance (SVR) and left ventricular minute
work (LVMW) (Table 1). These changes are accompanied by
baroreflex regulation inhibition of blood circulation, which is
characterized by an increase in the pressure adjusted heart rate
(PAR) and reduced cardiac pumping capacity index (CPCI).
Three hours (±10 min) after sorbilact infusion, LVMV
was found to be reduced (by 7-8%, p<0.05) mainly due to
chronotropic regulation factor effect (HR reduced by 6%,
p<0.05) and SVR (reduced by 7%, p<0.05). At the same
time, despite the increase in CVP (by 7-8%, p<0.05), the
PAR and CPCI remained at the control level as compared to
patients with EIS.
Co-administration of sorbilact and L-arginine was accom-
panied by activation of LVMV and CPCI. Mean arterial pres-
sure and SVR were moderately reduced by 7-8% (p≤0.05)
and 15-16% (p≤0.05), respectively.
3. Conclusions
1. The use of standard therapy in patients with EIS pro-
vides sufficient hemodynamic stability.
2. Sorbilact infusion at a dose of 6-7 ml/kg body weight at
a rate of 7-8 ml/min was found to have a fairly moderate
effect on hemodynamic regulatory factors.
3. Co-administration of sorbilact and L-arginine is ac-
companied by an increase in SV and CO, activation
of LVMW alongside with a moderate decrease in MAP
and SVR.
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Table 1. Complex of circulatory system indicators during development of early secondary toxic autoaggression (M±m)
Groups
Indicator, units of
measure
Group I, SIRS (31
patients)
Group II, EIS+s.t. (27
patients)
Group III, EIS + s.t. +
sorbilact (29 patients)
Group IV, EIS + s.t.+
sorbilact +
arginine(30 patients)
HR, bpm 92.2±1.9 99.8±2.1* 93.1±2.2* 99.7±2.1*
SP, mmHg 131.8±2.4 136.2±2.5 139.3±2.7 131.4±2.5*
DP, mmHg 73.3±1.4 79.4±1.5* 77.6±1.4 72.3±1.1* **
MAP, mmHg 92.5±2.1 98.7±2.3* 97.3±2.0 90.9±1.7* **
SV, mL 71.1±1.7 67.3±1.7 70.9±1.4 74.6±1.3* **
CO, L/min 6.47±0.14 6.60±0.15 6.71±0.12 7.35±0.11* **
SVR, dyn·s/cm5 1140.5±22.1 1244.2±23.7* 1158.7±21.0* 980.1±19.7* **
LVSW, gM 87.4±1.7 91.1±1.8 93.5±1.6 91.7±1.5
LVMW, kgM 8.1±0.11 9.2±0.10* 8.6±0.09* 9.0±0.08*
CVP, mmHg 5.3±0.13 6.4±0.15* 6.9±0.13* 6.5±0.12*
CPCI, cond.un. 15.9±0.35 12.8±0.32* 12.4±0.31 14.2±0.29***
Notes:
* – statistically significant difference between parameters of Groups I-II, Groups II-III and Groups III-IV;
** – statistically significant difference between parameters of Groups II-IV;
s.t. – standard therapy;
HR – heart rate;
SP – systolic pressure;
DP – diastolic pressure;
MAP – mean arterial pressure;
CO – cardiac output;
LVSW – left ventricular stroke work.
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